CRDF NASDAQ
Cardiff Oncology, Inc.
1W: -9.7%
1M: +5.7%
3M: -13.8%
YTD: -57.9%
1Y: -46.1%
3Y: -30.0%
5Y: -84.8%
$1.12
-0.06 (-5.08%)
Weekly Expected Move ±11.0%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$1M
Revenue
-7.0% YoY
$-40M
Net Income
+21.5% YoY
$-41M
Free Cash Flow
+2.3% YoY
100.0%
Gross Margin
-9245.2%
Op. Margin
-8876.9%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-94.1%
ROA-70.8%
ROIC443.4%
Valuation
P/E-1.9
P/B2.9
EV/EBITDA-1.4
Leverage
Debt/Equity0.02
Current Ratio3.30
Interest Cov.0.0x
Quality Scores
Piotroski F3/9
Altman Z-14.73
Beneish M-52.42